What does Life Stem Genetics Inc. do?

Life Stem Genetics Inc. (LIFS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is LIFS's market cap?

Life Stem Genetics Inc. (LIFS) has a market capitalization of approximately $4,584, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does LIFS pay a dividend?

No — Life Stem Genetics Inc. (LIFS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

LIFS

Life Stem Genetics Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$4.58K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

+0.00%CAGR +0.00%

Select date range

FromTo

Oct 22, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

LIFS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$10.35K

Net Margin—

Operating Cash Flow—

Capital Expenditures—

Free Cash Flow—

Return on Equity—

Return on Invested Capital0.0%

Net Debt—

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for LIFS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how LIFS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LIFS and 80,000+ other tickers.

About Life Stem Genetics Inc.

Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung…

CEO: Gloria Simov
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 0
Website: www.lifestemgenetics.com

Peers

Peers Tab

INFIQ

Infinity Pharmaceuticals, Inc.

Cap

$9.1K

ARDS

Aridis Pharmaceuticals, Inc.

Cap

$4.5K

EVLO

Evelo Biosciences, Inc.

Cap

$1.9K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About LIFS

What does Life Stem Genetics Inc. do?: Life Stem Genetics Inc. (LIFS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is LIFS's market cap?: Life Stem Genetics Inc. (LIFS) has a market capitalization of approximately $4,584, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does LIFS pay a dividend?: No — Life Stem Genetics Inc. (LIFS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.